Bausch Health Companies Inc. (BHC) - Insider Holders & Insider Ownership

List of insiders holdings for Bausch Health Companies Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Paulson John
Director		2026-07-02 16:11:53430,242
73,255,869		73,686,111Form 4
2PAULSON & CO. INC.
10% Owner		2025-11-28 17:38:390
73,255,869		73,255,869Form 4
3UBBEN JEFFREY W
ValueAct Holdings L.P.
ValueAct Capital Master Fund L.P.
ValueAct Co-Invest Master Fund L.P.
VA Partners I LLC
ValueAct Capital Management L.P.
ValueAct Capital Management LLC
ValueAct Holdings GP LLC
See Remarks		2022-05-12 17:43:1314,430,901
0		14,430,901Form 13D
4Morfit G Mason
ValueAct Holdings L.P.
ValueAct Capital Master Fund L.P.
ValueAct Co-Invest Master Fund L.P.
VA Partners I LLC
ValueAct Capital Management L.P.
ValueAct Capital Management LLC
ValueAct Holdings GP LLC
See Remarks		2022-05-12 17:43:1314,430,901
0		14,430,901Form 13D
5ValueAct Holdings L.P.
ValueAct Capital Master Fund L.P.
ValueAct Co-Invest Master Fund L.P.
VA Partners I LLC
ValueAct Capital Management L.P.
ValueAct Capital Management LLC
ValueAct Holdings II L.P.
ValueAct Holdings GP LLC
See Remarks		2022-05-12 17:43:1314,430,901
0		14,430,901Form 13D
6Hale David Robert
ValueAct Holdings L.P.
ValueAct Capital Master Fund L.P.
VA Partners I LLC
ValueAct Capital Management L.P.
ValueAct Capital Management LLC
ValueAct Holdings II L.P.
ValueAct Holdings GP LLC
See Remarks		2022-05-12 17:43:1314,430,901
0		14,430,901Form 13D
7APPIO THOMAS
Chief Executive Officer		2026-03-03 17:41:013,453,236
0		3,453,236Form 4
8PAPA JOSEPH C
Director		2022-05-12 21:12:591,427,568
0		1,427,568Form 4
9Carson Seana
EVP, General Counsel		2026-03-03 17:43:08754,683
0		754,683Form 4
10Charhon Jean-Jacques
EVP, CFO		2026-03-03 17:45:21706,478
0		706,478Form 4
11Kellen Ari
EVP, Company Group Chairman		2016-12-07 16:47:49630,842
0		630,842Form 4
12Vadaketh Tom George
EVP, Chief Financial Officer		2023-09-06 16:29:54564,933
0		564,933Form 4
13Rosiello Robert L.
EVP, Corp Dev & Strategy		2016-12-07 16:40:23517,683
0		517,683Form 4
14Pearson J. Michael
Chief Executive Officer		2016-01-05 19:30:21465,588
0		465,588Form 4
15Lenar Aimee J.
EVP, US Pharma		2026-02-27 17:21:50400,335
0		400,335Form 4
16DE SCHUTTER RICHARD U
Director		2023-04-04 18:02:01373,407
13,800		387,207Form 4
17Herendeen Paul
EVP and CFO		2021-03-10 20:59:29386,618
0		386,618Form 4
18Schiller Howard Bradley
Chairman and CEO		2016-02-22 17:39:52336,784
0		336,784Form 4
19WECHSLER AMY B
Director		2026-07-02 16:13:36314,979
0		314,979Form 4
20POWER ROBERT N
Director		2026-05-26 19:00:09300,594
0		300,594Form 4
21KAVANAGH SARAH B
Director		2026-05-26 18:19:05282,230
0		282,230Form 4
22DE SILVA RAJIV
President and COO		2013-01-08 18:45:09259,767
0		259,767Form 4
23Mulligan Margaret Jean
EVP, CFO		2010-11-15 19:50:19250,000
0		250,000Form 4
24Miller Steven D
Director		2025-05-20 16:31:41229,224
10,000		239,224Form 4
25Humphries William D.
President, Ortho-Dermatologics		2020-12-08 16:23:38235,035
0		235,035Form 4
26ROBERTSON RUSSEL C
Director		2024-04-01 16:30:53225,279
0		225,279Form 4
27MELAS KYRIAZI THEO
Director		2016-05-04 17:11:30223,087
0		223,087Form 4
28ICAHN BRETT
Director		2025-07-02 16:38:51220,280
0		220,280Form 4
29Barresi John S
SVP, Controller & CAO		2025-03-03 16:08:20192,268
0		192,268Form 4
30ACKERMANN CHRISTINA
EVP AND GENERAL COUNSEL		2022-03-11 16:00:43162,240
0		162,240Form 4
31Ross Thomas W. Sr.
Director		2023-05-19 16:24:30161,516
0		161,516Form 4
32Whitaker Anne Clem
EVP, Company Group Chairman		2016-12-20 18:26:21158,544
0		158,544Form 4/A
33Mulligan Richard
Director		2025-05-20 16:29:29155,616
0		155,616Form 4
34Loberg Philip Walden Jr
EVP, Interim CFO		2011-07-27 16:18:18145,065
0		145,065Form 4
35Provencio Norma Ann
Director		2016-05-04 17:15:34144,899
0		144,899Form 4
36Garcia Christian A
Director		2026-05-26 18:10:45135,578
0		135,578Form 4
37Stolz Brian M.
EVP, Administration & CHCO		2015-06-24 16:20:32125,280
0		125,280Form 4
38Chai-Onn Robert Roswell
EVP, CLO, General Counsel		2016-05-16 16:20:12124,815
0		124,815Form 4
39KARABELAS ARGERIS N
Director		2022-06-28 16:38:34123,715
0		123,715Form 4
40Hanson Jason David
EVP, Company Group Chairman		2012-12-13 16:17:36120,800
0		120,800Form 4
41Eldessouky Sam
EVP & Chief Financial Officer		2022-03-07 17:41:22119,455
0		119,455Form 4
42Weldon Ryan
EVP, Company Group Chairman		2014-04-30 16:57:14114,409
0		114,409Form 4
43Wechsler Daniel Mark
EVO, Co. Grp. Chmn, Eye Health		2013-08-14 17:28:26113,600
0		113,600Form 4
44Spurr Robert
President, U.S. Businesses		2022-05-12 21:03:29112,741
0		112,741Form 4
45Godin Gilbert
EVP & COO		2010-07-07 15:54:1899,902
0		99,902Form 4
46Kornwasser Laizer
EVP, Company Group Chairman		2015-04-28 16:07:4598,824
0		98,824Form 4
47LEUNG SANDRA
Director		2026-07-02 16:10:2097,070
0		97,070Form 4
48Lee Frank D.
Director		2026-05-26 18:25:0295,210
0		95,210Form 4
49Gordon Joseph F
Pres&Co-Head Bausch&Lomb/Int'l		2022-03-10 16:03:4593,139
0		93,139Form 4
50INGRAM ROBERT ALEXANDER
Director		2017-04-04 17:53:5392,046
0		92,046Form 4
51Masterson Richard Kevin
Pres. & COO, Valeant Intl. BB		2012-05-14 17:33:4689,524
0		89,524Form 4
52GOETTLER MICHAEL
Director		2026-05-26 18:14:2376,020
0		76,020Form 4
53Wells William McDowall
Director		2010-12-08 18:51:0875,000
0		75,000Form 4
54LEE STEVEN HYOSIG
SVP, Controller & CAO		2026-02-27 17:23:0573,239
0		73,239Form 4
55Mayer Christine
SVP, BTA Pharmaceuticals, Inc.		2010-10-06 15:00:2572,754
0		72,754Form 4
56Gubitz Gregory David
SVP, Corp. Devel. & GC		2010-07-07 16:09:1171,733
0		71,733Form 4
57Mirovsky Pavel
EVP, Pres. & GM Valeant EMENA		2015-06-24 16:27:0569,525
0		69,525Form 4
58Fibiger Hans Christian
Chief Scientific Officer		2010-10-06 15:22:2565,745
0		65,745Form 4
59Durham Mark Andrew
SVP Human Resources		2011-05-13 13:48:1761,595
0		61,595Form 4
60PAUL LAURENCE E
Director		2012-06-05 16:57:3760,459
0		60,459Form 4
61Hassan Fred
Director		2013-09-03 17:17:5453,969
0		53,969Form 4
62Lanthier John Spencer
Director		2010-07-06 16:19:1946,195
0		46,195Form 4
63ROBERTS EIRY
Director		2026-05-26 19:02:2545,871
0		45,871Form 4
64Laidley David H.
Director		2010-07-06 15:54:3645,328
0		45,328Form 4
65GOUIN SERGE
Director		2010-07-06 15:28:5745,328
0		45,328Form 4
66PARRISH MARK W
Director		2010-07-06 16:27:0743,605
0		43,605Form 4
67Hall Susan
Global Head of R&D		2013-07-30 18:02:3443,109
0		43,109Form 4
68Squires Douglas John Paul
Director		2010-07-06 15:14:4741,283
0		41,283Form 4
69VON ESCHENBACH ANDREW C.
Director		2021-08-09 16:13:5538,647
0		38,647Form 4
70Farmer Ronald Harold
Director		2016-05-04 17:06:0238,447
0		38,447Form 4
71JORN DEBORA
EVP, Company Group Chairman		2015-11-24 16:20:1434,812
0		34,812Form 4
72LONNER ANDERS
Director		2015-05-27 15:32:4429,891
0		29,891Form 4
73STEVENSON KATHARINE BERGHUIS
Director		2015-05-27 15:54:5124,705
0		24,705Form 4
74Potter Frank
Director		2010-07-07 11:27:5524,510
0		24,510Form 4
75Munsch Frederick
SVP, Controller and CAO		2022-05-05 16:12:5622,435
0		22,435Form 4
76Segal Lloyd Mitchell
Director		2013-06-18 16:23:0621,174
0		21,174Form 4
77McKenna Mark C.
President, Salix		2019-08-21 16:15:1320,756
0		20,756Form 4
78Tull Louis Randall
Director		2010-07-07 11:12:4816,580
0		16,580Form 4
79Chouinard Michel
COO, Biovail Labs. Intl SRL		2010-12-27 11:57:1513,367
0		13,367Form 4
80Van Every Michael Robert
Director		2011-05-23 19:07:356,397
0		6,397Form 4
81GOGGINS COLLEEN A
Director		2015-05-27 15:22:174,973
0		4,973Form 4
82ESHELMAN FREDRIC N
Director		2018-05-03 16:39:460
0		0Form 4
83Pershing Square Capital Management L.P.
PS Management GP LLC
ACKMAN WILLIAM A
See footnote (3)		2017-05-03 16:13:300
0		0Form 4
84Fraidin Stephen
See Remarks		2017-05-03 16:12:070
0		0Form 4